Below is an example of a common conversation being had with brokers several times a week. Since the Circuit Court Rulings late last year allowed Large Dialysis Organizations (LDO’s) to weaponize the Medicare as Secondary Payer Act (MSP), many plans…
[Phoenix, AZ] — March 25, 2021 — Renalogic, a leader in dialysis cost containment and risk management, has received the 2021 Gallup Exceptional Workplace Award (GEWA). This award recognizes the most engaged workplace cultures in the world. In a year…
Phoenix, AZ —March 10, 2021— Renalogic, Inc., the industry leader in dialysis risk management and cost containment, announced today that John R. Christiansen has joined the company as Executive Vice President of Legal Risk and Strategy. The announcement comes…
Leader in dialysis risk management and cost containment poised for accelerated growth and service offering expansion PHOENIX, AZ & SAN FRANCISCO, CA (March 3, 2021) – Carrick Capital Partners (Carrick), a growth-oriented investment firm focused on software and software-enabled businesses…
RENALOGIC U&R IS AN MSP SAFE HARBOR AND AN INDUSTRY LEADER; ALTERNATIVE METHODOLOGIES ARE NOT. BACKGROUND Dialysis claims costs are a significant health plan financial exposure, and a profit center for DaVita and Fresenius that control almost 90% of all…
We are disruptors, innovators; always doing more than others on behalf of members and clients. Our team put those qualities on full display in a challenging business year due to the ongoing Covid-19 pandemic. The hard work resulted in what…
Cost containment alone is no longer the gold standard when it comes to managing risks associated with Chronic Kidney Disease (CKD). It’s better to avoid catastrophic dialysis and CKD claims costs altogether. Now, CareINSIGHTS.ai enables Renalogic to manage cohort risks…
Executive Summary Multiple-of-Medicare (“MoM”) repricing is a popular and common cost containment strategy used by many plans and repricing companies for dialysis claims repricing. Renalogic has intentionally chosen to stay away from MoM methods because of the high risk of…
The first appellate court decision in the DaVita Medicare Secondary Payor Act (“MSPA”) cases has come down. This decision, in DaVita v. Marietta Hospital, came down in DaVita’s favor and is probably taking a lot of people by surprise. The…
The Latest Development in Dialysis Carves in Pacific Northwest Dialysis In recent years the Pacific Northwest has been the venue for repeated disputes between the large dialysis organizations (“LDOs”) Fresenius and DaVita and payors trying to manage very high LDO…
All Rights Reserved 2021
